60 Degrees Pharmaceuticals, Inc. (SXTP)
Nasdaq: SXTP · Pharmaceutical Preparations · Washington, DC · filing with the SEC since 2022
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 30, 2026 | Mar 27, 2025 | Apr 1, 2024 | · |
| Revenue | 1,005,471 | 607,574 | 253,573 | 223,208 |
| For lenders | ||||
| Net interest income | · | · | 1,341,033 | -4,426,839 |
| Cost of revenue | 781,695 | 384,765 | 474,550 | 432,370 |
| Gross profit | 223,776 | 222,809 | -220,977 | -209,162 |
| Research and development | 2,106,156 | 4,986,526 | 691,770 | 525,563 |
| General and administrative | 6,279,823 | 5,025,235r | 4,241,836 | 1,303,722 |
| Total operating expenses | 8,385,979 | 10,011,761r | 4,933,606 | 1,829,285 |
| Operating income | -7,758,579 | -9,715,181r | -5,154,583 | -1,750,445 |
| Interest expense | 7,805 | 7,912 | 2,286,637 | 3,989,359 |
| Interest income (expense), net | · | 1,759,518 | 1,341,033 | · |
| Other income (expense), net | 131,970 | 101,464 | -83,116 | -43,238 |
| Total non-operating income (expense) | 390,254 | 1,759,518 | · | · |
| Income before income taxes | -7,368,325 | -7,955,663r | -3,813,550 | -6,177,284 |
| Income tax expense | 0 | 0r | 250 | 500 |
| Income from continuing operations | · | · | -220,977 | 78,840 |
| Net income including non-controlling interests | -7,368,325 | -7,955,663 | -3,813,800 | -6,177,784 |
| Net income to non-controlling interests | -3,167 | -8,556 | -48,098 | 3,936 |
| Net income | -7,365,158 | -7,947,107 | -3,765,702 | -6,181,720 |
| Net income to common shareholders | -7,859,087 | -8,430,498 | -3,924,563 | -6,183,847 |
| Earnings per share, basic | -11.73 | -74.17r | -236.72rb | -626.40b |
| Earnings per share, diluted | -11.73 | -74.17r | -236.72rb | -626.40b |
| Weighted average shares, basic | 670,211 | 113,665r | 16,578rb | 9,866b |
| Weighted average shares, diluted | 670,211 | 113,665r | 16,578rb | 9,866b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-4 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpenseInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding